APR Applied Pharma Research s.a.
APR Applied Pharma Research s.a.'s Overview
APR Applied Pharma Research S.A. is a Swiss-based, fully integrated specialty pharmaceutical company focused on developing and commercializing science-driven, patent-protected healthcare solutions. Acquired by Relief Therapeutics Holding SA in 2021, APR specializes in orally disintegrating drug formulations and treatments for rare or niche diseases. Leveraging its proprietary drug delivery technologies (such as TEHCLO®, UnidDose®, and LiproS®), APR aims to improve therapy adherence and patient outcomes. Key therapeutic areas include inherited metabolic disorders, central nervous system disorders, and supportive care.
Where is APR Applied Pharma Research s.a.'s Headquarters?
HQ Function
The headquarters serves as the primary center for research and development, corporate management, strategic operations, manufacturing oversight, and commercialization activities for APR's specialized pharmaceutical products.
Notable Features:
The facility is equipped with advanced research laboratories and development infrastructure essential for its focus on innovative drug delivery technologies and pharmaceutical formulations. Specific architectural highlights are not widely publicized.
Work Culture:
As a research-intensive pharmaceutical company, the work culture at APR's headquarters emphasizes innovation, scientific rigor, collaboration, and a commitment to quality, aligning with Swiss precision and pharmaceutical industry standards.
HQ Significance:
The Balerna headquarters is crucial for APR's operations, providing a centralized R&D and administrative hub. Its location in Switzerland offers a stable regulatory environment and proximity to European markets and research networks.
Values Reflected in HQ: The headquarters embodies APR's dedication to scientific excellence, patient-centric innovation, and high-quality pharmaceutical development, crucial values for addressing unmet medical needs.
Location:
As a part of Relief Therapeutics, APR Applied Pharma Research S.A. benefits from an expanding global reach. Its products are commercialized through direct sales, licensing, and distribution agreements in various international markets, including Europe and the United States. The company actively seeks to broaden its market access for its specialized treatments for rare diseases and products based on its proprietary drug delivery platforms.
Street Address:
Via Corti 5
City:
Balerna
State/Province:
Ticino
Country:
Switzerland
APR Applied Pharma Research s.a.'s Global Presence
Buying Intent Signals for APR Applied Pharma Research s.a.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Executive Team of APR Applied Pharma Research s.a.
As of April 2025, APR Applied Pharma Research s.a.' leadership includes:
Investors of APR Applied Pharma Research s.a.
APR Applied Pharma Research s.a. has been backed by several prominent investors over the years, including:
Executive New Hires/Exits in the Last 12 Months
Executive changes in the last 12 months have primarily occurred at the parent company, Relief Therapeutics, which directly oversees APR. Notable movements include changes in the Chief Financial Officer role at Relief Therapeutics.
Departures
New Appointments:
Technology (Tech Stack) used by APR Applied Pharma Research s.a.
Discover the tools APR Applied Pharma Research s.a. uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
APR Applied Pharma Research s.a. Email Formats and Examples
Email addresses at APR Applied Pharma Research S.A. typically use the @apr.ch domain. Common formats include combinations of first name and last name, or first initial and last name.
[first_initial].[last]@apr.ch
Format
p.galfetti@apr.ch
Example
75%
Success rate
News and media
GlobeNewswire • April 30, 2024
Relief Therapeutics Reports Full Year 2023 Financial Results, Highlights APR's Contributions
Relief Therapeutics announced its 2023 financial results, detailing revenues primarily driven by APR's commercial products like PKU GOLIKE®. The report also covered APR's ongoing R&D projects and commercial activities....more
GlobeNewswire • January 24, 2024
Relief Therapeutics Updates on U.S. Commercial Operations for APR's PKU GOLIKE®
Relief Therapeutics provided an update on its U.S. commercial strategy and operations for PKU GOLIKE®, an APR-developed product line for Phenylketonuria, highlighting efforts to expand patient access and market presence....more
GlobeNewswire • December 18, 2023
Relief Therapeutics Announces Positive Phase 2 Results for PKU Treatment Involving APR's Technology
Relief Therapeutics reported positive topline results from its Phase 2 study of RLF-OD032 (Oral OltenLiproS) for Phenylketonuria (PKU), a novel formulation developed using APR's proprietary LiproS™ drug delivery technology....more
Highperformr’s free tools for company research
Explore Employees by Region or Country
See where a company’s workforce is located, by country or region.
View Funding Details
View past and recent funding rounds with amounts and investors.
Understand Revenue Insights
Understand company revenue estimates and financial scale.
Track Active Job Openings
Track active roles and hiring trends to spot growth signals.
Review Product and Offerings
Discover what a company offers—products, platforms, and solutions.
Get SIC or NAICS Codes
Get the company’s official SIC and NAICS classifications.
Analyze Website Traffic Trends
Analyze visitor volume, engagement, and top traffic sources.
Discover Social Profiles and Engagement
Explore LinkedIn, Twitter, and other active social profiles.
Identify Top Competitors
Identify top competitors based on similar business traits.
Research and Discover Companies with Highperformr — Smarter, Faster
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
- Track intent signals to find buyers who are actively in-market
- Enrich contacts and companies instantly, no need to switch tools
- Automate workflows to stay ahead of every change
- Connect your CRM & tools for seamless data sync and activation
Thousands of companies, including APR Applied Pharma Research s.a., are just a search away.